A Study to Evaluate Quality of Life, Psychological Impact, and End Organ Damage in Survivors of Severe Drug Eruptions

Overview

Información sobre este estudio

The purpose of this study is to determine the extent to which patients who survive severe drug eruptions suffer long-term end organ damage and experience decreased quality of life and psychological distress

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criterial:

  • Patients must be able to speak and understand English.
  • Participants must provide verbal informed consent.
  • Participants must be age 18 or older.
  • Both male and female patients will be included.
  • Patients must have received a diagnosis of “severe drug eruption,” either SJS/TEN or DRESS syndrome to be included.

Exclusion Criteria:

  • Children less than 18 years of age are excluded; there is reason to believe severe drug eruptions in this population have relatively better outcomes and potentially different psychological and quality of life effects than in an adult population.
  • Patients unable or unwilling to provide informed consent
  • Vulnerable populations will be excluded (children, fetuses, neonates, or prisoners).
  • Women will not be asked information about pregnancy and therefore, pregnant women are neither targeted for participation but also not excluded because the information will not be known.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus

Rochester, Minn.

Investigador principal de Mayo Clinic

Alexander Meves, M.D., M.B.A.

Cerrado para la inscripción

More information

Publicaciones

Publications are currently not available
.
CLS-20492865

Mayo Clinic Footer